Intellectual property (IP) is often misunderstood, leading to costly mistakes for businesses and individuals alike. Many ...
AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that support a wide moat. The strong replenishment of new drugs sets ...
Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed its intellectual ...
As 2025 unfolds, changes across the patent landscape are unfolding. From agency leadership transitions to proposed legislation and evolving ...
US patent law says inventors must be human, but they can use AI. This changes the nature of invention and raises the question ...
The rapid acceleration of AI deepfakes is alarming experts who say the technology is hijacking the identities of politicians and the average American.
Eric J. Fues and Kyle W. Howarth of Finnegan discuss decisions exploring the multi-pronged analysis in patent law for ...
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
IP developments In Indonesia In 2024. Legal News and Analysis - Indonesia - Intellectual Property - Conventus Law ...
In a precedential opinion issued on March 6, the Federal Circuit affirmed the US District Court for the Eastern District of Virginia that the claims in ImmunoGen’s US patent application 14/509,809 ...
The University of South Florida's patent prowess continues, with the university ranking among the nation's top 20 public ...
The nation’s highest patent court will rehear a case Thursday asking it to restrict the kinds of evidence expert witnesses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results